Cullinan Oncology Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cullinan Oncology Inc
TickerCGEM
CIK #0001789972
CUSIP230031106
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
AddressOne Main Street Suite 520, Cambridge, MA 02142
Source [EDGAR]
CIK Filing 2011 - 2026
[0001789972] 10-K
[0001789972] 10-Q
[0001789972] 3
[0001789972] 4
[0001789972] 5
[0001789972] 8-K
[0001789972] SC 13D
[0001789972] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Kynam Capital Management LP Cullinan Therapeutics Inc [2026-03-04] 0.0
Vanguard Group Inc Cullinan Therapeutics Inc [2026-01-30] 0.0
Lynx1 Capital Management LP Cullinan Therapeutics Inc [2025-08-14] 0.0
Citadel Advisors LLC Cullinan Therapeutics Inc [2025-08-06] 0.0
BlackRock Inc Cullinan Therapeutics Inc [2024-11-08] 7.5
BlackRock Inc Cullinan Therapeutics Inc [2024-10-22] 7.5
Flynn James E Cullinan Therapeutics Inc [2024-04-24] 5.71
Blue Owl Capital Holdings LP Cullinan Oncology Inc [2024-02-14] 7.99
Franklin Resources Inc Cullinan Oncology Inc [2024-02-06] 7.7
BlackRock Inc Cullinan Oncology Inc [2024-01-29] 5.8
BlackRock Inc Cullinan Oncology Inc [2023-02-03] 5.5
CHI Advisors LLC Cullinan Oncology Inc [2022-02-11] 5.67
Jovan-Embiricos Morana Cullinan Oncology Inc [2022-02-10] 4.8
Vanguard Group Inc Cullinan Oncology Inc [2022-02-09] 5.42
Biotechnology Value Fund L P Cullinan Oncology Inc [2021-11-08] 3.2
UBS Oncology Impact Fund LP Cullinan Management Inc [2021-01-19] 18.3
Foresite Capital Fund V LP Cullinan Management Inc [2021-01-15] 6.6
Form 3/4/5 Filer 2011 - 2026
Cullinan Therapeutics Inc
Michaelson Jennifer
Sumer Jacquelyn L
Fenton Mary Kay
Webster Stephen W
Allen Andrew R
Thistle Mary
Doyle Mittie
Rosenberg Anthony
Meek David D
Jones Jeffrey Alan
Ahmed Nadim
Savill Corrine
Nichols Weston
Lynx1 Capital Management LP
Martin Anne-Marie
Ryan David P
Ebeling Thomas
Nguyen Nate
Trigilio Jeffrey
Baeuerle Patrick
Gadicke Ansbert
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Jovan-Embiricos Morana
F2 Vision SCS
F2 Bioscience I 2017 Ltd
Zawel Leigh
Keane Raymond T
Oncology Impact Fund Cayman Management LP
MPM BioImpact LLC
UBS Oncology Impact Fund LP
MPM Oncology Impact Management GP LLC
F2 - TPO Investments LLC
F2 GC LLC
Globeways Holdings Ltd
F2 MC LLC
F2 MG Ltd
F2 Bio TD LLC
Hughes Owen
Wigginton Jon Marc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Michaelson Jennifer
Common Stock
2026-03-05 Sell 8,000 $15.68 125,440
Michaelson Jennifer
Stock Option (Right to Buy) · derivative
2026-03-05 Option exercise 4,000 $0.00
Michaelson Jennifer
Common Stock
2026-03-05 Option exercise 4,000 $4.30 17,200
Michaelson Jennifer
Common Stock
2026-02-25 Sell 1,780 $14.14 25,169
Ahmed Nadim
Common Stock
2026-02-24 Sell 13,515 $14.47 195,562
Sumer Jacquelyn L
Common Stock
2026-02-24 Sell 3,601 $14.47 52,106
Jones Jeffrey Alan
Common Stock
2026-02-24 Sell 4,582 $14.47 66,302
Michaelson Jennifer
Common Stock
2026-02-24 Sell 3,601 $14.47 52,106
Michaelson Jennifer
Common Stock
2026-02-23 Sell 1,752 $13.99 24,510
Sumer Jacquelyn L
Common Stock
2026-02-20 Sell 3,742 $13.62 50,966
Ahmed Nadim
Common Stock
2026-02-20 Sell 16,381 $13.62 223,109
Michaelson Jennifer
Stock Option (Right to Buy) · derivative
2026-02-20 Option exercise 8,000 $0.00
Michaelson Jennifer
Common Stock
2026-02-20 Option exercise 8,000 $4.30 34,400
Michaelson Jennifer
Common Stock
2026-02-20 Sell 3,742 $13.62 50,966
Michaelson Jennifer
Common Stock
2026-02-20 Sell 8,000 $14.30 114,400
Fenton Mary Kay
Common Stock
2026-02-20 Sell 4,398 $13.62 59,901
Jones Jeffrey Alan
Common Stock
2026-02-20 Sell 4,982 $13.62 67,855
Fenton Mary Kay
Stock Option (Right to Buy) · derivative
2026-02-18 Grant 137,500 $0.00
Ahmed Nadim
Stock Option (Right to Buy) · derivative
2026-02-18 Grant 828,000 $0.00
Jones Jeffrey Alan
Stock Option (Right to Buy) · derivative
2026-02-18 Grant 300,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 174 63,700,360
2025-12-31 154 63,294,413
2025-09-30 145 60,858,362
2025-06-30 144 63,315,177
2025-03-31 150 64,475,435
2024-12-31 148 65,722,806
2024-09-30 138 65,718,460
2024-06-30 136 62,999,837
2024-03-31 114 41,648,289
2023-12-31 114 37,833,248
2023-09-30 107 38,269,713
2023-06-30 107 36,881,027
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 80,648 80,648
TEMA ETFS LLC [2026-06-30] SOLE 62,826 62,826
Assenagon Asset Management SA [2026-06-30] SOLE 61,682 61,682
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 575 11,168
Curated Wealth Partners LLC [2026-06-30] OTR 0 10,000
Gamma Investing LLC [2026-06-30] DFND 1,928 1,928
Farther Finance Advisors LLC [2026-06-30] SOLE 0 849
Bangor Savings Bank [2026-06-30] SOLE 842 842
IFP Advisors LLC [2026-06-30] SOLE 728 728
Fortitude Family Office LLC [2026-06-30] SOLE 192 192
True Wealth Design LLC [2026-06-30] SOLE 0 71
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 27 27
Capital Advisors Ltd LLC [2026-06-30] SOLE 0 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com